The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.
Kenneth Bender, PharmD
Advertisement
Articles by Kenneth Bender, PharmD
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
How mRNA and Protein-Based COVID-19 Vaccines Work
4
Updated Guideline Refines Approach to Migraine Prevention in Adults
5